Kinetic characteristics of interaction of conotoxin with N-type Ca2+ channels in rat hippocampal neurons
- 14 Downloads
The binding and unbinding constants describing interaction of ω-CTx-GVIA with N-type Ca2+ channels were calculated based on the time course of the blocking action of the toxin. The experiments were carried out on pyramidal neurons freshly dissociated from theCA3 region of the rat hippocampus using a “concentration-clamp” technique and a patch-clamp technique in the whole-cell configuration. The bindingk 1 and unbindingk −1 constants were evaluated as 0.32 (μM·sec)−1 and 0.004 sec−1, respectively. The dissociation constantK D kinetically derived from the ratiok −1/k 1 was 0.012 μM. These values allow us to interpret the apparent “irreversibility” of the toxin action.
KeywordsGlobal Cerebral Ischemia Peripheral Neuron Simple Kinetic Model Toxin Molecule Chick Sensory Neurone
Unable to display preview. Download preview PDF.
- 12.A. Buchan, S. Z. Gertler, H. Li, et al., “A selective N-type Ca2+ channel blocker preventsCA1 injury 24 hours following severe forebrain ischemia and reduces infarction following focal ischemia,”J. Cerebr. Blood Flow Metab., Nov., Abstr.14:6, 903–910 (1994).Google Scholar
- 13.T. Singh, T. Gadbois, K. L. Valentino, et al., “24-hour infusion of SNX-111 protects against neuronal death after global cerebral ischemia with minimal adverse effects,”Soc. Neurosci. Abstr.,19, 850 (1993).Google Scholar
- 14.M. L. Smith and B. K. Siesjo, “Postischemia treatment with omega-conopeptide SNX-111 protects the rat brain against ischemic damage,” in:Pharmacology of Cerebral Ischemia, J. Krieglstein and H. Oberpilcher (eds.), Wissenschaftliche Verlag, Stuttgart (1992), pp. 161–167.Google Scholar
- 16.D. Xue, Z. G. Huang, K. Barnes, et al., “SNX-111 reduces neocortical infarction despite intra- and post-ischemic hypotension following focal ischemia,”Soc. Neurosci. Abstr.,19, 1643 (1993).Google Scholar
- 18.S. Takizawa, K. Matsushima, Y. Shinohara, et al., “A selective N-type calcium channel antagonist reduces extracellular glutamate release and infarct volume,”J. Cerebr. Blood Flow Metab., Nov., Abstr. 14:6, 911–918 (1994).Google Scholar